Found 6 matching trials
Nilotinib Plus Dabrafenib/Trametinib or Encorafenib/Binimetinib in Metastatic Melanoma PHASE1 This is a phase 1 dose-escalation study of nilotinib in combination with fi...
Show More Location
University of Iowa
Learn More & Join Trial
Extension Study of IDEAL (Imatinib) for Chronic Myelgenous Leukemia (CML) N/A This study is an extension study (prospective observational study) of 'IDEA...
Show More Location
Seoul National University Bundang Hospital
Learn More & Join Trial
Asciminib & Standard-of-Care Integration in Maintenance Therapy for POST Allogeneic Stem Cell Transplant (Allo-HSCT) of Patient With Ph+ B-ALL or Blastic Transformed CML PHASE2 The goal of this clinical trial is to learn if Asciminib, a first in class ...
Show More Location
The University of Hong Kong
Learn More & Join Trial
Philadelphia Chromosome Positive CML Patients Without Optimal Response or Tolerance to Bcr-Abl TKI PHASE1 A Phase I/II multicenter study of IY5511HCl in Philadelphia chromosome posi...
Show More Location
Local institution
Learn More & Join Trial
Dasatinib Versus Nilotinib for Treatment NaΓ―ve Chronic Myeloid Leukemia PHASE3 DANIN study is a randomized, phase 3 clinical trial comparing 'head to head...
Show More Location
National Center for Cancer Care & Research (NCCCR)
Learn More & Join Trial
TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia PHASE2 The purpose of this study is to evaluate the efficacy of tyrosine kinase in...
Show More Location
Department of Hematology,Nanfang Hospital, Southern Medical University
Learn More & Join Trial